Viewing Study NCT02220868


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-02-03 @ 5:20 AM
Study NCT ID: NCT02220868
Status: COMPLETED
Last Update Posted: 2016-08-04
First Post: 2014-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study
Sponsor:
Organization: